Literature DB >> 8197171

Down syndrome phenotypes: the consequences of chromosomal imbalance.

J R Korenberg1, X N Chen, R Schipper, Z Sun, R Gonsky, S Gerwehr, N Carpenter, C Daumer, P Dignan, C Disteche.   

Abstract

Down syndrome (DS) is a major cause of mental retardation and congenital heart disease. Besides a characteristic set of facial and physical features, DS is associated with congenital anomalies of the gastrointestinal tract, an increased risk of leukemia, immune system defects, and an Alzheimer-like dementia. Moreover, DS is a model for the study of human aneuploidy. Although usually caused by the presence of an extra chromosome 21, subsets of the phenotypic features of DS may be caused by the duplication of small regions of the chromosome. The physical map of chromosome 21 allows the molecular definition of the regions duplicated in these rare cases of partial trisomy. As a first step in identifying the genes responsible for individual DS features and their pathophysiology, a panel of cell lines derived from 16 such individuals has been established and the molecular break points have been determined using fluorescence in situ hybridization and Southern blot dosage analysis of 32 markers unique to human chromosome 21. Combining this information with detailed clinical evaluations of these patients, we have now constructed a "phenotypic map" that includes 25 features and assigns regions of 2-20 megabases as likely to contain the genes responsible. This study provides evidence for a significant contribution of genes outside the D21S55 region to the DS phenotypes, including the facies, microcephaly, short stature, hypotonia, abnormal dermatoglyphics, and mental retardation. This strongly suggests DS is a contiguous gene syndrome and augurs against a single DS chromosomal region responsible for most of the DS phenotypic features.

Entities:  

Mesh:

Year:  1994        PMID: 8197171      PMCID: PMC43917          DOI: 10.1073/pnas.91.11.4997

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

Authors:  P Erickson; J Gao; K S Chang; T Look; E Whisenant; S Raimondi; R Lasher; J Trujillo; J Rowley; H Drabkin
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

2.  A boy with Down's syndrome having recombinant chromosome 21 but no SOD-1 excess.

Authors:  K Miyazaki; T Yamanaka; N Ogasawara
Journal:  Clin Genet       Date:  1987-12       Impact factor: 4.438

3.  Assignment of the human aggrecan gene (AGC1) to 15q26 using fluorescence in situ hybridization analysis.

Authors:  J R Korenberg; X N Chen; K Doege; J Grover; P J Roughley
Journal:  Genomics       Date:  1993-05       Impact factor: 5.736

4.  Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype.

Authors:  J R Korenberg; H Kawashima; S M Pulst; T Ikeuchi; N Ogasawara; K Yamamoto; S A Schonberg; R West; L Allen; E Magenis
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

5.  Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis.

Authors:  J R Korenberg; C Bradley; C M Disteche
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

6.  Physical mapping around the Alzheimer disease locus on the proximal long arm of chromosome 21.

Authors:  M J Owen; L A James; J A Hardy; R Williamson; A M Goate
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

Review 7.  High-resolution chromosome analysis in clinical medicine.

Authors:  J J Yunis; M E Chandler
Journal:  Prog Clin Pathol       Date:  1978

8.  The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05.

Authors:  J R Korenberg; S M Pulst; R L Neve; R West
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

9.  Partial trisomy 21.

Authors:  S M Pueschel; T Padre-Mendoza; R Ellenbogen
Journal:  Clin Genet       Date:  1980-11       Impact factor: 4.438

Review 10.  Growth and development of the brain in Down syndrome.

Authors:  L Becker; T Mito; S Takashima; K Onodera
Journal:  Prog Clin Biol Res       Date:  1991
View more
  171 in total

1.  Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications.

Authors:  B Zheng; M Sage; E A Sheppeard; V Jurecic; A Bradley
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Perfect conserved linkage across the entire mouse chromosome 10 region homologous to human chromosome 21.

Authors:  T Wiltshire; M Pletcher; S E Cole; M Villanueva; B Birren; J Lehoczky; K Dewar; R H Reeves
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

3.  A contiguous 3-Mb sequence-ready map in the S3-MX region on 21q22.2 based on high- throughput nonisotopic library screenings.

Authors:  T Hildmann; X Kong; J O'Brien; L Riesselman; H M Christensen; E Dagand; H Lehrach; M L Yaspo
Journal:  Genome Res       Date:  1999-04       Impact factor: 9.043

4.  2001 William Allan Award Address. From Down syndrome to the "human" in "human genetics".

Authors:  Charles J Epstein
Journal:  Am J Hum Genet       Date:  2001-12-26       Impact factor: 11.025

5.  Associations between human disease genes and overlapping gene groups and multiple amino acid runs.

Authors:  Samuel Karlin; Chingfer Chen; Andrew J Gentles; Michael Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-09       Impact factor: 11.205

6.  A case of apparent trisomy 21 without the Down's syndrome phenotype.

Authors:  D Avramopoulos; I Kennerknecht; G Barbi; D Eckert; J M Delabar; C Maunoury; A Hallberg; M B Petersen
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

Review 7.  Small RNA-mediated gene regulation in neurodevelopmental disorders.

Authors:  Abrar Qurashi; Peng Jin
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

8.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

9.  Down Syndrome - Genetics and Cardiogenetics.

Authors:  Vasilica Plaiasu
Journal:  Maedica (Bucur)       Date:  2017-09

10.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.